Mouse Anti-CSNK1A1 Recombinant Antibody (CBFYC-0422) (V2LY-0125-LY5)

Liu, G., Li, H., Zhang, W., Yu, J., Zhang, X., Wu, R., ... & Yu, R. (2021). Csnk1a1 inhibition modulates the inflammatory secretome and enhances response to radiotherapy in glioma. Journal of cellular and molecular medicine, 25(15), 7395-7406.

Xu, W., Huang, Z., Gan, Y., Chen, R., Huang, Y., Xue, B., ... & Zhang, S. (2020). Casein kinase 1α inhibits p53 downstream of MDM2‑mediated autophagy and apoptosis in acute myeloid leukemia. Oncology reports, 44(5), 1895-1904.

Huang, Q., Chen, L., Schonbrunn, E., & Chen, J. (2020). MDMX inhibits casein kinase 1α activity and stimulates Wnt signaling. The EMBO journal, 39(14), e104410.

Ebert, B. L., & Krönke, J. (2018). Inhibition of casein kinase 1 alpha in acute myeloid leukemia. New England journal of medicine, 379(19), 1873-1874.

Jiang, S., Zhang, M., Sun, J., & Yang, X. (2018). Casein kinase 1α: biological mechanisms and theranostic potential. Cell Communication and Signaling, 16(1), 1-24.

Ghoul, E., Chalhoub, E., & Abdel-Samad, R. (2018). PO-150 Modulation of the expression of casein kinase i isoform alpha in the initiation and progression of prostate cancer. ESMO Open, 3, A285.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols